PlainPharmaWatch

CMS Open Payments · Program Year 2024

Medexus Pharma, Inc.

Medexus Pharma, Inc. reported $75,594.05 in payments to 57 physicians and teaching hospitals across 57 transactions.

See the rankings → How this is sourced
$75.6K
Total payments
57
Transactions
57
Recipients
+$20.9K
General Payments vs PY2023

Medexus Pharma, Inc. reported $75,594.05 in payments to 57 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #1254 of 1,925 reporting manufacturers (0.0% of all US industry payments), averaging $1.3K per recipient across 3 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the editorial team.

The verdict

Medexus Pharma, Inc. pairs below-median payment volume with a broadly spread payment pattern across many recipients.

#1254
of 1,925 companies
0.0%
of all US industry payments
0.2%
paid to its single top recipient
3
payment categories

Release-over-release change

General Payments changed from PY2023 to PY2024

Medexus Pharma, Inc.'s CMS-reported General Payments increased by $20.9K (+38.3%) from PY2023 to PY2024. The comparison uses the same CMS manufacturer-by-payment-category summary for both years and excludes research and ownership or investment records.

CMS source labels for this exact identifier: PY2022: MEDEXUS PHARMA, INC.PY2023: MEDEXUS PHARMA, INC.PY2024: Medexus Pharma, Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$54.6KPY2024$75.6K
PY2023
$54,646.89
PY2024
$75,594.05

How Medexus Pharma, Inc. ranks nationally

Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.

Medexus Pharma, Inc.'s total vs. every reporting company

CMS Open Payments, Program Year 2024

$75,594 35th percentile higher than 35% of 1,925 reporting companies

$9–$28: 3 reporting companies (0%). Below this entry. $28–$87: 10 reporting companies (1%). Below this entry. $87–$270: 20 reporting companies (1%). Below this entry. $270–$838: 41 reporting companies (2%). Below this entry. $838–$2,603: 76 reporting companies (4%). Below this entry. $2,603–$8,084: 114 reporting companies (6%). Below this entry. $8,084–$25,112: 167 reporting companies (9%). Below this entry. $25,112–$78,003: 249 reporting companies (13%). This entry sits in this band. $78,003–$242,294: 295 reporting companies (15%). Above this entry. $242,294–$752,621: 270 reporting companies (14%). Above this entry. $752,621–$2,337,813: 263 reporting companies (14%). Above this entry. $2,337,813–$7,261,783: 200 reporting companies (10%). Above this entry. $7,261,783–$22,556,757: 133 reporting companies (7%). Above this entry. $22,556,757–$70,066,439: 45 reporting companies (2%). Above this entry. $70,066,439–$217,642,369: 26 reporting companies (1%). Above this entry. $217,642,369–$676,046,922: 13 reporting companies (1%). Above this entry. This company $9 $676,046,922 every reporting company, bucketed by value

Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Open Payments · 2024

What the Data Shows for Medexus Pharma, Inc.

$75,594.05: that is what Medexus Pharma, Inc. reported in payments to 57 physicians and teaching hospitals during Program Year 2024, spread across 57 transactions ($1.3K per transaction, $1.3K per recipient). The company sits at rank #1254 of 1,925, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.

30 transactions worth $73.5K make "Consulting Fee" the top general-payment category in the 3-category breakdown below, 97.3% of the reported total (see our methodology for how research and ownership payments are reported separately).

General Payment Breakdown by Type

Across 3 types of general payments, Medexus Pharma, Inc.'s largest category was "Consulting Fee" at $73.5K - 97.3% of the company's reported total.

How Medexus Pharma, Inc. divides its payments

General-payment categories, ordered by reported total

1. Consulting Fee$73.5K2. Food and Beverage$1.3K3. Travel and Lodging$776.80
Payment Type Amount Transactions
Consulting Fee $73.5K 30
Food and Beverage $1.3K 26
Travel and Lodging $776.80 1

Recipient Concentration in General Payments

The five largest recipient relationships account for $31,821.76 (42.1%) of $75,594.05 in this company's General Payments records across 48 recipients. This is a CMS Open Payments Program Year 2024 General Payments view only: it excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Medexus Pharma, Inc.

The five named recipients with the highest reported General Payments from this company

Randy D'amico$14.7KFilippo Milano$8.2KEneida Nemecek$3.4KAndromachi Scaradavou$3.4KSagar Patel$2.1K
  1. 1

    Randy D'amico

    $14,723.97 across 6 reported transactions

  2. 2

    Filippo Milano

    $8,197.79 across 5 reported transactions

  3. 3

    Eneida Nemecek

    $3,400.00 across 1 reported transactions

  4. 4

    Andromachi Scaradavou

    $3,400.00 across 1 reported transactions

  5. 5

    Sagar Patel

    $2,100.00 across 1 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Payment Size Analysis

Average transaction size: $1.3K. Average per recipient: $1.3K.

Total Amount

$75,594.05

Avg per Transaction

$1.3K

Avg per Recipient

$1.3K

Payment Transparency Context

What is the Sunshine Act?

The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.

Industry Total (2024)

$13.9B

across 1,925 companies

Medexus Pharma, Inc. Share

0.0%

#1254 by total payments

Companies with Similar Payment Volumes

Pharmaceutical companies with payment totals similar to Medexus Pharma, Inc.

Pinnacle Biologics, Inc

$75.4K 342 recipients

Clinician's Choice Dental Products Inc.

$76.0K 46 recipients

Advanced Sterilization Products Services Inc.

$76.1K 6 recipients

Kuros Biosciences AG

$76.3K 6 recipients

Biocon Biologics Inc

$76.3K 733 recipients

Evolution Surgical, Inc

$74.8K 667 recipients

Frequently Asked Questions

How much did Medexus Pharma, Inc. pay to physicians and hospitals in 2024? ▾
0.0% of all industry payments reported to CMS Open Payments for 2024 came from Medexus Pharma, Inc., totaling $75,594.05 across 57 transactions to physicians and hospitals.
How many physicians received payments from Medexus Pharma, Inc.? ▾
Averaging $1.3K per recipient, Medexus Pharma, Inc.'s 2024 payments reached 57 physicians and teaching hospitals.
What types of payments did Medexus Pharma, Inc. make? ▾
General payments from Medexus Pharma, Inc. span 3 distinct categories, covering things like consulting, meals, and travel. The largest general-payment category was "Consulting Fee" at $73.5K, representing 97.3% of the company's reported total.
How does Medexus Pharma, Inc. rank among pharmaceutical companies? ▾
Out of 1,925 companies in the CMS Open Payments database for 2024, Medexus Pharma, Inc. ranks #1254 by total payment amount.
What is the average payment size from Medexus Pharma, Inc.? ▾
Medexus Pharma, Inc.'s 57 transactions to 57 recipients in 2024 averaged $1.3K per transaction.
Where does the payment data for Medexus Pharma, Inc. come from? ▾
This data comes from the CMS Open Payments program (Sunshine Act), which requires pharmaceutical and medical device companies to report payments and transfers of value to physicians and teaching hospitals. The data covers Program Year 2024.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch Editorial
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Medexus Pharma, Inc.'s data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.